Cyclacel Pharmaceuticals Inc (CYCC):企業の財務・戦略的SWOT分析

◆英語タイトル:Cyclacel Pharmaceuticals Inc (CYCC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH37480FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cyclacel Pharmaceuticals Inc (CYCC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cyclacel Pharmaceuticals Inc (Cyclacel) is a biopharmaceutical company that develops oral therapies. The company develops small molecule drugs that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Its products include sapacitabine, seliciclib, CDK inhibitor and PLK inhibitor. Cyclacel’s sapacitabine is the drug candidate used to treat the patients with acute myeloid leukemia. The company’s seliciclib is an orally available, cyclin dependent kinase inhibitor. It offers products for the treatment of anti-infective, autoimmune, cardiovascular, ophthalmic and other non-oncology indications. The company operates in the US and the UK. Cyclacel is headquartered in Berkeley Heights, New Jersey, the US.

Cyclacel Pharmaceuticals Inc Key Recent Developments

Mar 16,2021: Cyclacel Pharmaceuticals Announces Closing of $14.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Mar 15,2021: Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference
Feb 25,2021: Cyclacel Pharmaceuticals reports fourth quarter and full year 2020 financial results
Feb 19,2021: Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2020 Financial Results
Feb 10,2021: Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cyclacel Pharmaceuticals Inc – Key Facts
Cyclacel Pharmaceuticals Inc – Key Employees
Cyclacel Pharmaceuticals Inc – Key Employee Biographies
Cyclacel Pharmaceuticals Inc – Major Products and Services
Cyclacel Pharmaceuticals Inc – History
Cyclacel Pharmaceuticals Inc – Company Statement
Cyclacel Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cyclacel Pharmaceuticals Inc – Business Description
R&D Overview
Cyclacel Pharmaceuticals Inc – Corporate Strategy
Cyclacel Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Cyclacel Pharmaceuticals Inc – Strengths
Cyclacel Pharmaceuticals Inc – Weaknesses
Cyclacel Pharmaceuticals Inc – Opportunities
Cyclacel Pharmaceuticals Inc – Threats
Cyclacel Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cyclacel Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2021: Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference
Feb 25, 2021: Cyclacel Pharmaceuticals reports fourth quarter and full year 2020 financial results
Feb 19, 2021: Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2020 Financial Results
Feb 10, 2021: Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference
Jan 11, 2021: Cyclacel Pharmaceuticals reviews 2020 achievements and announces key business objectives for 2021
Dec 30, 2020: Cyclacel Pharmaceuticals to present at Biotech Showcase Digital 2021
Dec 21, 2020: Cyclacel Pharmaceuticals announces that Brian Schwartz, M.D. was elected to its board of directors
Nov 11, 2020: Cyclacel Pharmaceuticals reports third quarter 2020 financial results
Oct 23, 2020: Cyclacel Pharmaceuticals announces appointment of Mark Kirschbaum, M.D., as chief medical officer
Oct 05, 2020: Cyclacel Pharmaceuticals to present at the October 2020 Lytham Partners Virtual Investor Growth Conference
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cyclacel Pharmaceuticals Inc, Key Facts
Cyclacel Pharmaceuticals Inc, Key Employees
Cyclacel Pharmaceuticals Inc, Key Employee Biographies
Cyclacel Pharmaceuticals Inc, Major Products and Services
Cyclacel Pharmaceuticals Inc, History
Cyclacel Pharmaceuticals Inc, Other Locations
Cyclacel Pharmaceuticals Inc, Subsidiaries
Cyclacel Pharmaceuticals Inc, Key Competitors
Cyclacel Pharmaceuticals Inc, Ratios based on current share price
Cyclacel Pharmaceuticals Inc, Annual Ratios
Cyclacel Pharmaceuticals Inc, Annual Ratios (Cont...1)
Cyclacel Pharmaceuticals Inc, Interim Ratios
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cyclacel Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cyclacel Pharmaceuticals Inc (CYCC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaccinogen Inc (Vaccinogen) is an immunotherapy company that develops products for the treatment of solid tumors. The company provides oncovax products. It provides immunotherapy products to treat solid tumors and commercializes autologous tumor vaccine products. Vaccinogen's products are us …
  • GATC Biotech AG-製薬・医療分野:企業M&A・提携分析
    Summary GATC Biotech AG (GATC Biotech) is a healthcare service center that offers sequencing services. The center products category include nextgen, liquid biopsy, tissue biopsy, sanger and cell culture. It offers nextgen products such as inview transcriptome, inview metagenome, inview microbiome, i …
  • Nova Eye Medical Ltd (EYE):企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alabama Municipal Electric Authority:企業の発電所・SWOT分析2018
    Alabama Municipal Electric Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Linde AG (LIN)-医療機器分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • Kansas City Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Kansas City Power & Light Co. (KCP&L), a subsidiary of Great Plains Energy, Inc., is an integrated energy utility that generates, transmits, distributes, and sells electricity. The company generates electricity from nuclear, solar, biogas, wind, hydro, coal, and natural gas sources. Through …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alimentation Couche-Tard Inc (ATD.B):石油・ガス:M&Aディール及び事業提携情報
    Summary Alimentation Couche-Tard Inc (Couche-Tard) is a retail company that operates an extensive network of convenience stores. The company principally offers food and non-food items as well as transportation fuels. Couche-Tard products include tobacco, alcohol, grocery items, candy, snacks and var …
  • Calfrac Well Services Ltd. (CFW)-石油・ガス分野:企業M&A・提携分析
    Summary Calfrac Well Services Ltd. (Calfrac) is an oilfield services company. It operates as an independent provider of specialized oilfield services. The company offers various specialized services such as hydraulic fracture-stimulation, coiled tubing, well simulation, fracturing, acidizing, frac d …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務情報
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SuccessFactors, Inc.:企業の戦略的SWOT分析
    SuccessFactors, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sanford Health:医療機器:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Valeura Energy Inc (VLE):石油・ガス:M&Aディール及び事業提携情報
    Summary Valeura Energy Inc (Valeura) is an upstream oil and gas company that explores for, develops and produces oil and natural gas. It operates mainly in the Thrace Basin in the northwest of Turkey pursuing conventional shallow natural gas, unconventional tight gas and a basin-centered gas accumul …
  • Volkswagen AG:企業の戦略・SWOT・財務分析
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Windtree Therapeutics Inc (WINT):医療機器:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Robert W. Baird & Co. Private Wealth Management:企業の戦略・SWOT・財務情報
    Robert W. Baird & Co. Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Robert W. Baird & Co. Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Advance Syntex Ltd:企業の戦略的SWOT分析
    Advance Syntex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependa …
  • Bruce Power L.P.:企業の戦略的SWOT分析
    Bruce Power L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆